Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
VSA-1 is a semisynthetic saponin adjuvant prepared from naturally occurring Momordica saponin and capable of stimulating antigen-specific humoral and cellular immune responses. Its immunostimulating activity in enhancing the immune responses induced by the clinical glycoconjugate pneumococcal vaccin...
Main Authors: | Hyunjung Kim, Jigui Yu, Di Bai, Moon H. Nahm, Pengfei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1079047/full |
Similar Items
-
Natural and Synthetic Saponins as Vaccine Adjuvants
by: Pengfei Wang
Published: (2021-03-01) -
Exploring the possible use of saponin adjuvants in COVID-19 vaccine
by: Rinku Sharma, et al.
Published: (2020-12-01) -
Potentials of saponins-based adjuvants for nasal vaccines
by: Kai Chen, et al.
Published: (2023-03-01) -
Saponins from Momordica charantia exert hypoglycemic effect in diabetic mice by multiple pathways
by: Yuanyuan Deng, et al.
Published: (2023-12-01) -
Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
by: Nancy Vázquez-Maldonado, et al.
Published: (2023-08-01)